Log In
BCIQ
Print this Print this
 

M2698, MSC 2363318A

  Manage Alerts
Collapse Summary General Information
Company Merck KGaA
DescriptionDual p70-S6K/AKT inhibitor
Molecular Target Protein kinase B (AKT) (AKT1) (PKB) (PKBA) ; Ribosomal protein S6 kinase 70kDa polypeptide 1 (RPS6KB1) (S6K1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today